Real-world data as an evidence source in nuclear medicine
08 April 2022
- RWE use is becoming particularly relevant in oncology, as only a small percentage of adult cancer patients worldwide are enrolled in clinical trials whereas the number of therapeutic options and the segmentation of patient populations are rapidly increasing, leading to the explosive growth of research questions and evidence gaps
- High-quality RWE from electronic health records (EHRs) is increasingly recognised as an opportunity to fill evidence gaps, especially for applications for which prospective clinical studies are infeasible or when the potential benefit of the diagnostic or therapeutic intervention is large
- Nuclear medicine technology, in both diagnostics and therapeutics, represents a remaining frontier that could benefit from new insights derived from RWE